Marcella Martignoni

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial

Toni K. Choueiri, James Larkin, Mototsugu Oya et al. · The Lancet Oncology · 2018 · 257 citations

Phase 1B, Urology, Oncology +7

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer

Andrea Sartore‐Bianchi, Elena Ardini, Roberta Bosotti et al. · JNCI Journal of the National Cancer Institute · 2015 · 245 citations · Full text

Radiation Oncology, Systems Biology, Oncology +15

COMPARISON OF MOUSE AND RAT CYTOCHROME P450-MEDIATED METABOLISM IN LIVER AND INTESTINE

Marcella Martignoni, Geny M. M. Groothuis, Ruben de Kanter · Drug Metabolism and Disposition · 2006 · 99 citations · Full text

An in vivo and in vitro comparison of CYP induction in rat liver and intestine using slices and quantitative RT-PCR

Marcella Martignoni, Ruben de Kanter, Pietro Grossi et al. · Chemico-Biological Interactions · 2004 · 66 citations

Hepatology, Quantitative Rt-pcr, Gastrointestinal Pharmacology +9

Chapter 13 Enantioselective recognition of two anticonvulsants, FCE 26743 and FCE 28073, by MAO, and relationship between MAO-B inhibition and FCE 26743 concentrations in rat brain

M. Strolin Benedetti, Paola Tocchetti, Maria Teresa Rocchetti et al. · Progress in brain research · 1995 · 61 citations

Neurophysiology, Medicine, Neurotransmitter +11